Showing results (131-140 of 174) with videos related to

Sort By:
Pageof 18
Alimentary Pharmacology & Therapeutics|May 6, 2022
Response-guided long-term treatment of chronic hepatitis D patients with bulevirtide-results of a "real world" studyMathias Jachs, Caroline Schwarz, Marlene Panzer, et al.
JHEP Reports : Innovation in Hepatology|July 17, 2025
Risk of portal hypertensive complications preventable by TIPS in patients with ascitesLorenz Balcar, Marta Tonon, Joan Valls, et al.
Wiener Klinische Wochenschrift|September 4, 2025
Effectiveness of controlled-expansion transjugular intrahepatic portosystemic shunt (CX-TIPS) in an interdisciplinary setting at a large tertiary centerMarlene Hintersteininger, Julia Kappel, Theresa Müllner-Buscics, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 9, 2026
Prognostication of Liver Disease Patients via the WFUMB 'Rule-of-4' Algorithm Using SSI-2D-SWE-Based Liver Stiffness MeasurementChristian Sebesta, Georg Kramer, Nina Dominik, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 18, 2025
Neutrophil Extracellular Traps Are Not Linked to Decompensation, ACLF, or Death in Clinically Stable Patients With ACLDLorenz Balcar, Bernhard Scheiner, Benedikt Simbrunner, et al.
The American Journal of Gastroenterology|April 22, 2026
Sex does not impact the performance of non-invasive tests for clinically significant portal hypertension in cACLDPaula Höfinger, Helena Schluchter, Georg Semmler, et al.
Journal of Hepatology|January 23, 2022
Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLDBernhard Scheiner, Lorenz Balcar, Rosa Johanna Nussbaumer, et al.
Alimentary Pharmacology & Therapeutics|January 23, 2026
The Alpha-1 Pi*MZ Genotype Is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients With ACLDLorenz Balcar, Georg Semmler, Bernhard Scheiner, et al.
Pageof 18